Table 3 MPXI and biochemical measurements of the study cohorts

Number of patients

30

30

30

MPXI

1.02 ± 3.01

3.22 ± 3.03

3.52 ± 4.25

0.013*

0.016*

0.007*

0.745

PSGL1, ng/mL

581.07 ± 162.45

450.76 ± 166.43

379.93 ± 114.75

0.000*

0.001*

0.000*

0.070

E-selectin, ng/mL†

6.49(2.65–17.82)

4.74(1.91–14.32)

3.06(1.45–4.86)

0.036*

0.401

0.011*

0.082

L-selectin, ng/mL

1186.86 ± 356.62

1118 ± 631.53

801.05 ± 190.33

0.002*

0.539

0.001*

0.006*

IL1β, pg/mL† (%)

46.1 ± 121.09 (73.3)

19.72 ± 30.24 (46.7)

4.14 ± 14.79 (16.7)

0.000 (0.000*)

0.296 (0.035)

0.000* (0.000*)

0.018* (0.012*)

IL8, pg/mL† (%)

20.38 ± 88.5 (10)

0.54 ± 2.93 (3.3)

0 ± 0 (0)

0.161 (0.160)

TNFα, pg/mL† (%)

1.58 ± 8.56 (6.7)

0.15 ± 0.8 (3.3)

0 ± 0 (0)

0.360 (0.355)

IL17, pg/mL† (%)

3.21 ± 17.37 (6.7)

7.36 ± 26.2 (16.7)

0.29 ± 1.59 (3.3)

0.169 (0.168)

dsDNA, ng/mL†

284.31(258.33–449.91)

225.12(203.34–257.13)

247.37(231.04–273.01)

0.000*

0.000*

0.001*

0.041*

SLPI, ng/mL

52.24 ± 18.41

44.47 ± 14.57

40.02 ± 6.80

0.004*

0.207

0.005*

0.352